Guaifenesin 76162-0031-56
- Manufacturer
- Topco Associates Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- April 22, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA210453
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 1200 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Selected Package
76162-0031-56Selected4 BLISTER PACK in 1 CARTON (76162-031-56) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK